Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00993343
What this trial is testing

Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft-versus-host DiseaseSurvival
Karolinska Institutet 215
Large-scale testing (Phase 3)UnknownNCT03695055
What this trial is testing

Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma

Who this might be right for
High-risk Aggressive Lymphoma After Auto-HSCT
Fujian Medical University 60
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Not applicableStudy completedNCT07747246
What this trial is testing

Retrospective Study of Romiplostim for Platelet Engraftment After Allo-HSCT

Who this might be right for
Thrombocytopenia
Tongji Hospital 103
Testing effectiveness (Phase 2)Study completedNCT03236220
What this trial is testing

Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT05799079
What this trial is testing

Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Who this might be right for
Recurrent Acute Myeloid Leukemia
Sanjay Mohan 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755319
What this trial is testing

Safety and Feasibility of FMT for Immune Recovery After HSCT

Who this might be right for
Humoral ImmunodeficiencyHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05688241
What this trial is testing

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Who this might be right for
EBV LymphomaPost-transplant Lymphoproliferative Disease (PTLD)
University Hospital, Basel, Switzerland 10
Not applicableStudy completedNCT07181330
What this trial is testing

Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)CMV Reactivation+1 more
Ting YANG 60
Not applicableLooking for participantsNCT07500441
What this trial is testing

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Testing effectiveness (Phase 2)Looking for participantsNCT06529731
What this trial is testing

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Sawa Ito, MD 57
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Ended earlyNCT01790295
What this trial is testing

Ruxolitinib Prior to Transplant in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost Polycythemia Vera MyelofibrosisPost Essential Thrombocythemia Myelofibrosis
John Mascarenhas 21
Large-scale testing (Phase 3)Study completedNCT00120575
What this trial is testing

Hemofiltration for Respiratory Failure After Bone Marrow Transplantation

Who this might be right for
Bone Marrow TransplantationRespiratory Insufficiency
Stanford University 6
Testing effectiveness (Phase 2)Study completedNCT00499577
What this trial is testing

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland Greenebaum Cancer Center 56
Not applicableUnknownNCT01491230
What this trial is testing

Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Childhood Cancer
Tel-Aviv Sourasky Medical Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06252870
What this trial is testing

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancy
Nantes University Hospital 82
Large-scale testing (Phase 3)Study completedNCT00075829
What this trial is testing

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 710
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Next Page